Concentrix Corp (STU:CO8)
€ 24.97 +1.02 (+4.26%) Market Cap: 1.54 Bil Enterprise Value: 5.26 Bil PE Ratio: 0 PB Ratio: 0.66 GF Score: 59/100

Q1 2025 Concentrix Corp Earnings Call Transcript

Mar 26, 2025 / 09:00PM GMT
Release Date Price: €41.6 (+0.48%)

Key Points

Positve
  • Concentrix Corp (CNXC) reported year-over-year revenue and profitability growth above guidance for Q1 2025.
  • The company has successfully deployed GenAI solutions at scale, positioning itself as a leader in AI deployment.
  • Revenue from top 25 clients continues to outpace the growth rate of the rest of the business, indicating strong client relationships.
  • The iX Hello product suite is gaining traction, with thousands of seats deployed and expected to be accretive to earnings by the end of fiscal 2025.
  • Concentrix Corp (CNXC) has a strong liquidity position with approximately $1.5 billion, including an undrawn line of credit.
Negative
  • Revenue growth in the healthcare vertical was flat year-over-year, indicating potential challenges in this sector.
  • The company is facing a negative impact from foreign exchange rates, affecting revenue growth.
  • Adjusted free cash flow was a use of $40 million in Q1, although this was an improvement from the previous year.
  • There is a need for ongoing investment in AI and technology, which could pressure margins in the short term.
  • The macroeconomic environment remains muted, with no significant improvement expected in the near term.
Operator

Good day and thank you for standing by. Welcome to Concentrix's first-quarter 2025 earnings call.

At this time, all participants are in a listen only mode. Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Sara Buda, Vice President, Investor Relations.

Sara Buda
Concentrix Corp - Vice President, Investor Relations

Great. Thank you, operator, and good evening. Welcome to the Concentrix's first-quarter 2025 earnings call.

This call is the property of Concentrix and may not be recorded or rebroadcast without the written permission of Concentrix. This call contains forward-looking statements that address our expected future performance in that by their nature address matters that are uncertain. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements.

We do not undertake to update our forward-looking statements as a result of new information or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot